Concomitantly, persistent expression of PD-1 on memory CD8+ T cells in the TME, along with other immunosuppressive components and tumor-intrinsic features, could reduce and/or prevent antigen-specific antitumor activity of CD8+ T cell. This evidence concerns the gene CD8A and neoplasm.